Medizinische Universität Graz - Research portal
Koch Catharina |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** Ziehfreund, S; Saak, M; Schaal, A; Mazilu, R; Mahé, E; Hajj, C; Johansson, EK; Lysell, J; Sigurdardottir, G; Legat, FJ; Koch, C; Schmieder, A; Glatzel, C; Kirby, B; Pender, E; Zalewska-Janowska, A; Tomaszewska, K; Ciccarese, G; Lauriola, P; Boffa, MJ; Farrugia, S; Pilz, AC; Schauer, F; Trzeciak, M; Zysk, W; Gáspár, K; Szegedi, A; Damiani, G; Carugno, A; Hartmane, I; Mikazans, I; Valiukeviciene, S; Petrokaite, L; Szepietowski, JC; Jastrzab, B; Staubach, P; Hadzavdic, SL; Buzina, DS; Posch, C; Jochmann, J; Wiala, A; Scheffenbichler, L; Trovato, E; Calabrese, L; Fekete, GL; Chernyshov, P; Kolodzinska, L; Welzel, J; Thölken, K; Maul, J; Maul, LV; Meyersburg, D; Bowe, S; Connor, CO; Darlenski, R; Traidl, S; Vestergaard, C; Pinto-Pulido, EL; Konstantinou, MP; Szlávicz, E; Heidemeyer, K; Yawalkar, N; Lantzsch, HAC; Soplinska, A; Seitz, A; Torres, T; Brzoza, Z; Vucemilovic, AS; Manolache, L; Magnolo, N; Scala, E; Eyerich, K; Biedermann, T; Zink, A
Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact
J EUR ACAD DERMATOL. 2025; PMID 9216037
Doi: 10.1111/jdv.70245
Web of Science
PubMed
FullText
FullText_MUG
2021
Full paper/article (Journal)
** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12):
Doi: 10.3390/cancers13123101
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Abstract (Journal)
** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakic, E; Richtig, G; Richtig, E; Rohrer, P; Koch, L; Wolf, I; Koch, C; Rainer, B; Koeller, M; Pichler, M; Kashofer, K; Aigelsreiter, A
Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
ONCOL RES TREAT. 2020; 43(SUPPL 4):166-167.
[Onlinepräsentation]
Web of Science